Food Grade & Pharma Grade Calcium Phosphate Market Overview

According to a new report published by Introspective Market Research, titled, “Food Grade & Pharma Grade Calcium Phosphate Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2024–2032,”

Global Food Grade & Pharma Grade Calcium Phosphate market size was valued at $ 327.38 million in 2023, and is projected to reach $ 498.8 million by 2032, registering a CAGR of 4.79% from 2024 to 2032.  

Food- and Pharma-Grade Calcium Phosphate is a highly refined calcium phosphate variant that meets stringent standards for food and pharmaceutical use. Derived from natural sources like minerals or bones, it undergoes meticulous processing to ensure purity and safety, adhering to regulatory mandates. This form of calcium phosphate is notable for its high bioavailability, which facilitates easy absorption in the body, making it an excellent source of calcium and phosphorus—essential minerals for bone health, dental strength, and various metabolic functions. Its lack of taste and odor and its recognition as generally safe make it suitable for a wide range of food and pharmaceutical products.

In the food industry, calcium phosphate acts as a nutrient booster in baked goods, beverages, dairy alternatives, and dietary supplements, enhancing calcium content without affecting taste or consistency. In pharmaceuticals, it serves as a supplement for calcium and phosphorus in medications and dental products like toothpaste. Its regulated purity and high bioavailability make it vital for nutritional fortification and health benefits in many consumable and medicinal items.

The market for Food- and Pharma-Grade Calcium Phosphate is experiencing significant growth, driven by expanding pharmaceutical applications. Calcium phosphate plays a crucial role in various medicinal formulations, including tablets, capsules, and oral medications, enhancing their effectiveness, stability, and absorption. Its biocompatibility and natural breakdown capabilities make it a preferred choice in drug delivery systems, dental applications, and bone grafts. The increasing prevalence of chronic diseases affecting bone health, such as osteoporosis and hypocalcemia, further fuels the demand for calcium phosphate in pharmaceuticals.

Additionally, ongoing research and development exploring new therapeutic uses and advanced formulations continue to drive demand in the pharmaceutical sector. The growing consumer demand for fortified foods also presents a substantial market opportunity. Health-conscious consumers increasingly seek functional foods that offer added health benefits, such as improved bone health and overall wellness. Calcium phosphate is ideal for fortifying a wide range of food and beverage products, meeting this demand. By leveraging the trend of preventive health and dietary choices aimed at addressing health concerns, manufacturers can drive market growth for Food- and Pharma-Grade Calcium Phosphate.

Global Food Grade & Pharma Grade Calcium Phosphate Market, Segmentation

The Food Grade & Pharma Grade Calcium Phosphate market is segmented based on type, application, and region.

Type:

The type segment is further classified into TCP, DCP, MCP. Among these, the TCP sub-segment accounted for the highest market share in 2023.  Tricalcium Phosphate (TCP) holds a dominant position in the Food- and Pharma-Grade Calcium Phosphate market due to its versatile applications and high calcium content. Widely used in food products, supplements, and pharmaceuticals, TCP enhances bone health and supports calcium fortification without altering taste or texture. Its application spans dairy alternatives, baked goods, and nutritional supplements, meeting the rising consumer demand for bone-strengthening products. TCP's GRAS (Generally Recognized as Safe) status and compatibility with various formulations reinforce its market dominance, making it a key ingredient in addressing calcium deficiency in numerous consumer and pharmaceutical products.

Application:

The application segment is further classified into Food, Beverage, Pharma. Among these, the Food sub-segment is anticipated to show the fastest growth by 2032. The food industry's demand for Food- and Pharma-Grade Calcium Phosphate has surged due to consumer preferences for health-conscious diets. Heightened health awareness has driven the need for fortified foods that offer added benefits. Calcium phosphate fortifies dairy alternatives, baked goods, cereals, and snacks by boosting calcium and phosphorus levels without altering taste or texture. Regulatory efforts promoting essential mineral fortification have further increased its prominence.

Region:

The Food Grade & Pharma Grade Calcium Phosphate market in North America is projected to show the fastest growth by 2032. North America leads the Food- and Pharma-Grade Calcium Phosphate market with its robust pharmaceutical and food sectors, adhering to stringent quality standards. A health-conscious population drives demand for fortified foods and medicines enriched with calcium phosphate, emphasizing bone health and wellness. Advanced healthcare infrastructure and ongoing research efforts support its use in medications targeting bone-related conditions. Technological advancements ensure top-quality manufacturing, meeting industry demands.

Some of The Leading/Active Market Players Are-

• Innophos (US)
• Budenheim (Germany)
• Hens (Germany)
• Biesterfeld (Germany)
• Alfacal (Spain)
• Prayon (Belgium)
• Icl Pp (Israel)
• Haifa Group (Israel)
• Gadot Biochemical (Israel)
• Chengxing Industrial (China) and Other Active Players

Key Industry Developments

In January 2023, Prayon, a significant figure in global phosphorus chemistry, announced the completion of its acquisition of Arkema's shares in Febex, a prominent player in the European electronics industry's phosphoric acid sector. With this acquisition, Prayon now holds a 97% ownership stake in Febex, headquartered in Bex, Switzerland. This positions Prayon as the primary shareholder in Febex, a company that employs approximately 60 individuals and achieved a turnover of €32 million in 2021. Febex is recognized as the foremost producer and distributor of electronic-grade phosphoric acid in Europe.

Key Findings of the Study 

• Food- and Pharma-Grade Calcium Phosphate, derived from natural sources and refined to meet stringent standards, is recognized for its high bioavailability, lack of taste or odor, and safety. It serves as a crucial source of calcium and phosphorus, essential for bone health, dental strength, and various metabolic functions.
• North America is projected to exhibit the fastest growth by 2032, owing to its robust pharmaceutical and food sectors, stringent quality standards, health-conscious population, and advanced healthcare infrastructure.
• Significant industry developments include Prayon's acquisition of Arkema's shares in Febex, positioning Prayon as the primary shareholder in Febex, a prominent producer and distributor of electronic-grade phosphoric acid in Europe.